Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Aprea Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 39 | 1 | 41 | +3 |
| Shares | 5.00M | 42.0K | 3.61M | −1.35M (−27.2%) |
| Value | $25.6M | $214.0K | $10.4M | −$15.0M (−59.1%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Aprea Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pura Vida Investments, LLC | 433,859 | $1.25M | 0.13% |
| Renaissance Technologies LLC | 281,923 | $809.0K | 0.00% |
| Virtu Financial LLC | 41,955 | $120.0K | 0.01% |
| Magnus Financial Group LLC | 33,981 | $98.0K | 0.02% |
| XTX Topco Ltd | 27,285 | $78.0K | 0.04% |
| ExodusPoint Capital Management, LP | 17,326 | $50.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 15,173 | $44.0K | 0.00% |
| Squarepoint Ops LLC | 14,880 | $43.0K | 0.00% |
| Engineers Gate Manager LP | 13,395 | $38.0K | 0.00% |
| FMR LLC | 200 | $1.00K | 0.00% |
| Wells Fargo & Company | 95 | $0 | 0.00% |
| UBS Group AG | 75 | $0 | 0.00% |
Sold out (9)
Institutions that held Aprea Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Versant Venture Management, LLC | 1,259,662 | $6.44M |
| Redmile Group, LLC | 694,918 | $3.55M |
| Jacobs Levy Equity Management, Inc | 53,201 | $272.0K |
| Simplex Trading, LLC | 3,970 | $21.0K |
| Skandinaviska Enskilda Banken AB (publ) | 2,160 | $11.0K |
| Citigroup Inc | 1,108 | $6.00K |
| Penserra Capital Management LLC | 490 | $2.00K |
| Koshinski Asset Management, Inc. | 55 | $281 |
| Daiwa Securities Group Inc. | 40 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Aprea Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Coastal Investment Management, L.P. | 41,965 | $214.0K |